Chapter 11 - Bowel
Showing all 166 results
-

Bowel 001 – Functional Bowl Disorders
$5.00 -

Bowel 002 – Different Models Explain Functional Bowel Disorders
$5.00 -

Bowel 003 – Functional Bowel Disorders are a Spectrum
$5.00 -

Bowel 004 – Overlap Between IBS-C and FC
-

Bowel 005 – Overlap Between IBS-C and FC
$5.00 -

Bowel 006 – Overlap Between IBS-C and FC
$5.00 -

Bowel 007 – Overlap Between IBS-C and FC or FDr
$5.00 -

Bowel 008 – Abdominal Bloating and Abdominal Distension
$5.00 -

Bowel 009 – Irritable Bowel Syndrome-Diagnostic Criteria
$5.00 -

Bowel 010 – Stool Form Depends on Water Content and Correlates with Transit Time
$5.00 -

Bowel 011 – IBS Subtypes-Stool Form is the Differentiating Factor
$5.00 -

Bowel 012 – IBS Patients May Switch From One Subtype to Another
$5.00 -

Bowel 013 – Pragmatic Issues in IBS
$5.00 -

Bowel 014 – Usefulness of Individual Symptoms in IBS Diagnosis
$5.00 -

Bowel 015 – Symptom-based Criteria for the Diagnosis of IBS Perform Poorly
$5.00 -

Bowel 016 – Diagnostic Criteria Used to Define IBS
$5.00 -

Bowel 017 – IBS Diagnosis
$5.00 -

Bowel 018 – History and Physical Examination for Lower GI Symptoms
$5.00 -

Bowel 019 – History-Clinical Criteria
$5.00 -

Bowel 020 – Alarm Features for Organic Disorders
$5.00 -

Bowel 021 – Diagnostic Strength of Red Flags
$5.00 -

Bowel 022 – Usefulness of Red Flags
$5.00 -

Bowel 023 – Proposed Pathophysiology of IBS
$5.00 -

Bowel 024 – IBS-Pathogenesis/Pathophysiology
$5.00 -

Bowel 025 – Genetic Influences on Intestinal Transit Effect of Mutation
$5.00 -

Bowel 026 – Conceptual Model of the Development of IBS
$5.00 -

Bowel 027 – Prevalence of Early Life Trauma in IBS and Healthy Controls
$5.00 -

Bowel 028 – Interaction Between Rectal Sensory and Motor Function in IBS
$5.00 -

Bowel 029 – Colonic Transit – IBS Radiopaque Markers
$5.00 -

Bowel 030 – High-Amplitude Propagated Contractions in Ileum Reflect Power
$5.00 -

Bowel 031 – Postprandial Jejunal Dysmotility is More Frequent in IBS Patients
$5.00 -

Bowel 032 – Rectal Barostat Sensory Test in IBS-Sensitivity and Specificity
$5.00 -

Bowel 033 – The Phenomena of Hyperalgesia and Allodynia
$5.00 -

Bowel 034 – Colonic Hypersensitivity to Barostat Distension in IBS
$5.00 -

Bowel 035 – Nutrient and Lactulose Challenge Test in IBS
$5.00 -

Bowel 036 – Mast Cells Infiltrate and Associate with Nerve Fibers in Colonic Mucosa
$5.00 -

Bowel 037 – Colonic Mucosal Supernatants from IBS Patients Increase Afferent
$5.00 -

Bowel 038 – Activation Increased in Limbic Regions Regions and Decreased in Pain
$5.00 -

Bowel 039 – Meta-Analysis-Differences in Brain Activation in IBS and Healthy Controls
$5.00 -

Bowel 040 – Differences in Brain Responses to Rectal Distension in Hypersensitive
$5.00 -

Bowel 041 – Degree of Abdominal Pain in IBS is Associated with Reduced Somatic
$5.00 -

Bowel 042 – Stress has Central Affects Affecting Mood, Cognition and Perception
$5.00 -

Bowel 043 – Colonic Distension Postprandially Provokes an Altered Autonomic
$5.00 -

Bowel 044 – Altered Autonomic Nervous System Responses to Colonic Distension
$5.00 -

Bowel 045 – Blunted Autonomic Nervous System Response During a Visceral Stressor
$5.00 -

Bowel 046 – CRF Signaling and Intestinal Inflammation
$5.00 -

Bowel 047 – Early Adverse Life Events Increase Cortisol Response to Visceral Stressor
$5.00 -

Bowel 048 – Effect of Infection on Risk of Developing IBS-Meta-analysis
$5.00 -

Bowel 049 – IBS Developing After Campylobacter jejuni Enteritis is Mostly IBS-D
$5.00 -

Bowel 050 – Accelerated Gut Transit and Visceral Hypersensitivity in PI-IBS
$5.00 -

Bowel 051 – Brain and Gut Factors Associated with Developing Postinfectious IBS
$5.00 -

Bowel 052 – IBS Patients with Inflammatory Bowel Disease
$5.00 -

Bowel 053 – Immune Activity in the Intestinal Mucosa and Blood in Patients with IBS
$5.00 -

Bowel 054 – Mucosal Immune Activation IBS vs IBD vs Healthy Controls
$5.00 -

Bowel 055 – Jejunal Mast Cell Hyperplasia and Activation is Present in IBS-D
$5.00 -

Bowel 056 – Atopy, Increase in Mast Cells, Permeability and Symptoms in IBS
$5.00 -

Bowel 057 – Sensory Neuro-Immune Interaction in IBS
$5.00 -

Bowel 058 – Adaptive Immune Activation in IBS Patients
$5.00 -

Bowel 059 – Adaptive Immune Activation in IBS Patients
$5.00 -

Bowel 060 – Increased 5-HT Availability in Postinfection IBS
$5.00 -

Bowel 061 – Mechanisms of Increased Serotonin Availability, Increased 5-HT Release
$5.00 -

Bowel 062 – Increased Small-Intestine Permeability is Present in Both PI-IBS and IBS
$5.00 -

Bowel 063 – IBS-Symptoms, Immune and Barrier Function-Relevance of Allergy
$5.00 -

Bowel 064 – Cross-talk at the Mucosal Barrier
$5.00 -

Bowel 065 – The Full Circle rRNA Approach
$5.00 -

Bowel 066 – Integrated Conceptual Framework of the Pathophysiology if IBS
$5.00 -

Bowel 067 – Index of Microbial Dysbiosis- IBS, Postinfectious IBS
$5.00 -

Bowel 068 – Phylogenetic Tree Gut Microbiota-IBS vs Controls
$5.00 -

Bowel 069 – An Irritable Bowel Syndrome Subtype Defined by Species-Specific
$5.00 -

Bowel 070 – Luminal and Mucosal Colonic Microbiotic and Their Role in Gut
$5.00 -

Bowel 071 – SIBO-Irritable Bowel Syndrome Lactulose Hydrogen Breath Test
$5.00 -

Bowel 072 – LHBT Measures Small Intestinal Transit Rather Than SIBO in IBS Patients
$5.00 -

Bowel 073 – Mild Increases of Small-Bowel Bacteria, but Not Overgrowth
$5.00 -

Bowel 074 – FODMAPs-IBS
$5.00 -

Bowel 075 – Factors in Affecting Gut Microbiota
$5.00 -

Bowel 076 – Nutrient Intake-Functional GI Disorders
$5.00 -

Bowel 077 – Food Intolerance-IBS Symptoms
$5.00 -

Bowel 078 – Psychosocial Factors-IBS
$5.00 -

Bowel 079 – Bile Acid Malabsorption in Persistent Diarrhea
$5.00 -

Bowel 080 – Increased Bile Acid Synthesis in IBS-D
$5.00 -

Bowel 081 – Increased Colonic Bile Acid Exposure in IBS “SeHCAT”
$5.00 -

Bowel 082 – Colonic Bile Acids-IBS
$5.00 -

Bowel 083 – In a 12 Week Randomized, Controlled Trial Which Included 102 IBS Patients
$5.00 -

Bowel 084 – Treatment Options for IBS-D
$5.00 -

Bowel 085 – Impact of Physical Activity on IBS ad IBS Severity Scoring System-IBS Score
$5.00 -

Bowel 086 – Benefits of a Gluten-free Diet in IBS Patties Without Celiac Disease
$5.00 -

Bowel 087 – Proposed Mechanisms of Non-Celiac Wheat Sensitivity
$5.00 -

Bowel 088 – A Low-FODMAP Diet Reduces Symptoms in IBS
$5.00 -

Bowel 089 – Polyethylene Glycol for IBS-C-Result from an RCT
$5.00 -

Bowel 090 – Intestinal Chloride Channels
$5.00 -

Bowel 091 – Lubiprostone for IBS-C-Data from 2 Phase III Trials
$5.00 -

Bowel 092 – Long-term Efficacy of Lubiprostone-Monthly Responder Rates
$5.00 -

Bowel 093 – Effects of Guanylate Cyclase-C Receptor Activation
$5.00 -

Bowel 094 – Linaclotide Phase III Studies in IBS-C-EMA Analysis
$5.00 -

Bowel 095 – Linaclotide Phase III Studies in IBS-C Trial
$5.00 -

Bowel 096 – Linaclotide Phase III IBS-C Trial-Harms
$5.00 -

Bowel 097 – Chenodeoxycholate (CDC) in Female Patients with IBS-C
$5.00 -

Bowel 098 – Loperamide for IBS with Diarrhea
$5.00 -

Bowel 099 – Eluxadoline for IBS-D
$5.00 -

Bowel 100 – Eluxadoline Daily Response- Weeks 0-26
$5.00 -

Bowel 101 – Eluxodoline-Adverse Events
$5.00 -

Bowel 102 – Antispasmodics for IBS
$5.00 -

Bowel 103 – Sustained Release Peppermint Oil Improves IBS Symptoms
$5.00 -

Bowel 104 – Antidepressant Action in IBS
$5.00 -

Bowel 105 – Antidepressant for IBS-Clinical Considerations
$5.00 -

Bowel 106 – Safety Profile of Alosetron
$5.00 -

Bowel 107 – Alosetron Improves Global Symptoms in Women with Severe IBS-D
$5.00 -

Bowel 108 – Ondansetron Relieves Loose Stools, Frequency and Urgency in IBS-D
$5.00 -

Bowel 109 – Bifidobacter Infantis for IBS-Results from Multicenter RCT
$5.00 -

Bowel 110 – Rifaximin for IBS with Diarrhea
$5.00 -

Bowel 111 – Re-treatment with Rifaximin in IBS-D
$5.00 -

Bowel 112 – Complementary and Alternative Medicine Therapy for IBS-Acupuncture
$5.00 -

Bowel 113 – Different Conceptual Ways of Understanding Constipation of Functional
$5.00 -

Bowel 114 – Functional Constipation
$5.00 -

Bowel 115 – Stool Form Depends on Water Content and Correlates with Transit Time
$5.00 -

Bowel 116 – Main Symptoms in Functional Constipation
$5.00 -

Bowel 117 – Different Conceptual Ways of Understanding Constipation of Functional
$5.00 -

Bowel 118 – Some Causes of Secondary Constipation
$5.00 -

Bowel 119 – Some Causes of Secondary Constipation
$5.00 -

Bowel 120 – Conceptual Categorization of Constipation
$5.00 -

Bowel 121 – Functional Constipation Can Be Divided into Three Broad Categories
$5.00 -

Bowel 122 – Functional Constipation Diagnostic Algorithm
$5.00 -

Bowel 123 – Functional Constipation Diagnosis
$5.00 -

Bowel 124 – Important Functions That Should be Assessed During Anorectal Digital
$5.00 -

Bowel 125 – Colonic Transit Study (Hilton Technique)
$5.00 -

Bowel 126 – Colonic Transit Study (Metcalf Technique)
$5.00 -

Bowel 127 – Importance of Circadian Rhythm and Feeding in Colonic Motility
$5.00 -

Bowel 128 – Exercise and Dietary Fiber Associated with Lower Risk of Constipation
$5.00 -

Bowel 129 – High-Amplitude Propagated Contractions Occur Less Frequently in Slow
$5.00 -

Bowel 130 – Pancolonic Spatiotemporal Mapping Reveals Regional Deficiencies
$5.00 -

Bowel 131 – Dysmotility of the Colon and Anorectum Reported in Functional
$5.00 -

Bowel 132 – Interstitial Cells of Cajal – Slow Transit Constipation
$5.00 -

Bowel 133 – Mucosal Serotonin Signaling is Altered in Chronic Constipation
$5.00 -

Bowel 134 – Squatting and Elevating Feet Can Facilitate Defecation
$5.00 -

Bowel 135 – Osmotic Laxatives-Sugars and Sugar Alcohols
$5.00 -

Bowel 136 – Osmotic Laxatives-Saline and PEG Laxatives
$5.00 -

Bowel 137 – PEG for Chronic Constipation
$5.00 -

Bowel 138 – Stimulant Laxatives-Classification and Mechanism of Action
$5.00 -

Bowel 139 – Effect of Lubiprostone on Stool Frequency in Chronic Idiopathic
$5.00 -

Bowel 140 – Linaclotide for Chronic Idiopathic Constipation-Primary Results
$5.00 -

Bowel 141 – Effect of Elobixibat on Weekly Stool Frequency Over 8 Weeks
$5.00 -

Bowel 142 – 5-HT4 Agonists
$5.00 -

Bowel 143 – Prucalopride-Efficacy Across Phase III-IV Studies
$5.00 -

Bowel 144 – Phase III Studies of Prucalopride for Chronic Constipation-Adverse Events
$5.00 -

Bowel 145 – Randomized Trial of Dried Plums for Chronic Constipation
$5.00 -

Bowel 146 – Randomized Trial of Hemp Seed Pill for Functional Constipation
$5.00 -

Bowel 147 – Functional Diarrhea-Diagnostic Criterion
$5.00 -

Bowel 148 – Functional Diarrhea Diagnosis
$5.00 -

Bowel 149 – Systematic Review of the Prevalence of Idiopathic Bile Acids
$5.00 -

Bowel 150 – Differential Diagnosis for Functional Diarrhea
$5.00 -

Bowel 151 – Evaluation of functional diarrhea
$5.00 -

Bowel 152 – Prevalence of idiopathic BA malabsorption in IBS-D (systematic review)
$5.00 -

Bowel 153 – Potential pathophysiologies for functional diarrhea
$5.00 -

Bowel 154a – Worldwide prevalence of bloating
$5.00 -

Bowel 154b – Worldwide prevalence of bloating
$5.00 -

Bowel 155 – Functional abdominal bloating_distension
$5.00 -

Bowel 156 – Functional abdominal bloating_distention diagnosis
$5.00 -

Bowel 157 – Production and absorption of gas in the GI tract
$5.00 -

Bowel 158 – Impedance plethysmography
$5.00 -

Bowel 159 – Pathophysiology of bloating
$5.00 -

Bowel 160 – Abdominal wall dystony associated with bloating
$5.00 -

Bowel 161 – Impaired viscerosomatic refluxes and abdominal wall dystony associated with bloating
$5.00 -

Bowel 162 – Functional Abdominal Bloating and Distension
$5.00 -

Bowel 163 – Treatment options for bloating
$5.00 -

Bowel 164 – Presumed sites of action for therapeutic agents used to treat bloating
$5.00 -

Bowel 165 – Differential effects of gas production with FODMAPs
$5.00
